BridgeMD
New treatment option for Gastroesophageal Reflux
Official title Sleeve-pex: A Randomized Trial to Reduce Reflux After Sleeve Gastrectomy
ClinicalTrials.gov ID: NCT05704348
What this study is testing
- What it's testing
- The goal of this clinical trial is to test gastropexy as a measure to reduce reflux in morbidly obese patients being submitted to sleeve gastrectomy. The main questions it aims to answer are: Does gastropexy reduce reflux symptoms?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients planned for bariatric surgery with primary LSG
You likely can't join if
- Age below 18 yrs
- Use of ARM for other reasons than reflux
- Previous antireflux surgery
- Inability to comprehend and respon to patient related outcome (PRO) questionnaire
The study team makes the final eligibility decision.
Where it's taking place
- Førde, Norway
- Oslo, Norway
- Volda, Norway
- Voss, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Førde, Norway; Oslo, Norway; Volda, Norway; Voss, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.